Axsome Therapeutics, Inc. short interest in 2024
In 2024, Axsome Therapeutics, Inc.'s disclosed short interest ran from 17.58% of shares outstanding on 12 Jan 2024 to 13.66% on 31 Dec 2024, a change of -3.92 percentage points. The year's high was 18.72% on 14 Jun 2024 and its low 13.45% on 13 Dec 2024, averaging 16.12% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.57 days on 30 Aug 2024. Full history: Axsome Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 17.58% (12 Jan 2024)
- End of year
- 13.66% (31 Dec 2024)
- Change
- -3.92 pp
- High
- 18.72% (14 Jun 2024)
- Low
- 13.45% (13 Dec 2024)
- Average
- 16.12%
- Highest days to cover
- 22.57 (30 Aug 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 17.58% | 10.72 | results (8-K) |
| 31 Jan 2024 | 15.83% | 12.84 | |
| 15 Feb 2024 | 15.86% | 14.48 | |
| 29 Feb 2024 | 15.77% | 7.57 | results (8-K), 10-K filed |
| 15 Mar 2024 | 15.40% | 7.24 | |
| 28 Mar 2024 | 16.15% | 10.36 | |
| 15 Apr 2024 | 16.36% | 14.35 | |
| 30 Apr 2024 | 16.23% | 14.23 | |
| 15 May 2024 | 15.98% | 12.06 | 10-Q filed, results (8-K) |
| 31 May 2024 | 17.42% | 16.17 | |
| 14 Jun 2024 | 18.72% | 9.65 | |
| 28 Jun 2024 | 18.07% | 9.40 | |
| 15 Jul 2024 | 17.44% | 12.24 | |
| 31 Jul 2024 | 16.96% | 15.83 | |
| 15 Aug 2024 | 15.97% | 15.15 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 15.86% | 22.57 | |
| 13 Sep 2024 | 15.98% | 14.52 | |
| 30 Sep 2024 | 16.16% | 20.29 | |
| 15 Oct 2024 | 15.66% | 16.75 | |
| 31 Oct 2024 | 15.79% | 20.71 | |
| 15 Nov 2024 | 15.86% | 11.40 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 14.60% | 14.19 | |
| 13 Dec 2024 | 13.45% | 14.72 | |
| 31 Dec 2024 | 13.66% | 7.54 |
See also: Axsome Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.